Molecular Biology Reports

, Volume 40, Issue 5, pp 3705–3711 | Cite as

Distribution and phenotypic expression of mineralocorticoid receptor and CYP11B2 T-344C polymorphisms in a Taiwanese hypertensive population

  • Sung-Kien Sia
  • Hui-Ling Chiou
  • Shiuan-Chih Chen
  • Chin-Feng Tsai
  • Shun-Fa Yang
  • Kwo-Chang Ueng


Numerous genetic loci are involved in the pathogenesis of hypertension, including genes related to aldosterone synthesis and mineralocorticoid receptor. The aim of this study was to evaluate the genotypic distribution of mineralocorticoid receptor and cytochrome P450 11B2 (CYP11B2) T-344C polymorphisms and their relationship with hypertension and cardiac remodeling in a Taiwanese population. Genomic DNA extracted from peripheral blood samples was subjected to polymerase chain reaction-restriction fragment length polymorphism (PCR–RFLP) analysis for the mineralocorticoid receptor loci, G3514C and A4582C, and CYP11B2 T-344C. The genetic distribution and the association with echocardiographic measurements were analyzed. A total of 192 normotensive and 514 hypertensive Taiwanese patients were recruited. Statistical analysis revealed no significant differences in the genetic distribution of mineralocorticoid receptor and CYP11B2 polymorphisms between normotensive and hypertensive patients, nor were there differences in the echocardiographic measurements. Female patients with the T/T genotype of CYP11B2 were more likely to have hypertension (p = 0.045), compared with the T/C or C/C genotypes. In addition, female hypertensive patients carrying C-allele had significantly greater left ventricular mass (p = 0.0215) and left atrial dimension (p = 0.0081). Such differences were not observed in the male patients. Our data suggest that CYP11B2 T-344C polymorphism affects left ventricular structures only in the female hypertensive population. This gender-difference needs to be further elucidated.


Mineralocorticoid receptor CYP11B2 Hypertension Cardiac remodeling Left ventricular mass 



This study was supported by research grants from Chung Shan Medical University Hospital, Taiwan (CSH-2009-C-002) and National Science Council, Taiwan (NSC 99-2314-B-040-020-MY2).


  1. 1.
    Poch E, Gonzalez D, Giner V, Bragulat E, Coca A, de La Sierra A (2001) Molecular basis of salt sensitivity in human hypertension. Evaluation of renin-angiotensin-aldosterone system gene polymorphisms. Hypertension 38:1204–1209PubMedCrossRefGoogle Scholar
  2. 2.
    Lifton RP (1996) Molecular genetics of human blood pressure variation. Science 272:676–680PubMedCrossRefGoogle Scholar
  3. 3.
    Freitas SR, Cabello PH, Moura-Neto RS, Dolinsky LC, Lima AB, Barros M et al (2007) Analysis of renin-angiotensin-aldosterone system gene polymorphisms in resistant hypertension. Braz J Med Biol Res 40:309–316PubMedCrossRefGoogle Scholar
  4. 4.
    Jansen PM, Danser AH, Imholz BP, van den Meiracker AH (2009) Aldosterone-receptor antagonism in hypertension. J Hypertens 27:680–691PubMedCrossRefGoogle Scholar
  5. 5.
    Lombes M, Alfaidy N, Eugene E, Lessana A, Farman N, Bonvalet JP (1995) Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase in the human heart. Circulation 92:175–182PubMedCrossRefGoogle Scholar
  6. 6.
    Tsukada K, Ishimitsu T, Teranishi M, Saitoh M, Yoshii M, Inada H et al (2002) Positive association of CYP11B2 gene polymorphism with genetic predisposition to essential hypertension. J Hum Hypertens 16:789–793PubMedCrossRefGoogle Scholar
  7. 7.
    Zhu H, Sagnella GA, Dong Y, Miller MA, Onipinla A, Markandu ND et al (2003) Contrasting associations between aldosterone synthase gene polymorphisms and essential hypertension in blacks and in whites. J Hypertens 21:87–95PubMedCrossRefGoogle Scholar
  8. 8.
    Barbato A, Russo P, Siani A, Folkerd EJ, Miller MA, Venezia A et al (2004) Aldosterone synthase gene (CYP11B2) C-344T polymorphism, plasma aldosterone, renin activity and blood pressure in a multi-ethnic population. J Hypertens 22:1895–1901PubMedCrossRefGoogle Scholar
  9. 9.
    Russo P, Siani A, Venezia A, Iacone R, Russo O, Barba G et al (2002) Interaction between the C(-344)T polymorphism of CYP11B2 and age in the regulation of blood pressure and plasma aldosterone levels: cross-sectional and longitudinal findings of the olivetti prospective heart study. J Hypertens 20:1785–1792PubMedCrossRefGoogle Scholar
  10. 10.
    Russo P, Loguercio M, Lauria F, Barba G, Arnout J, Cappuccio FP et al (2007) Age- and gender-dependent association of the -344C/T polymorphism of CYP11B2 with blood pressure in European populations. J Hum Hypertens 21:333–336PubMedGoogle Scholar
  11. 11.
    Foppa M, Duncan BB, Rohde LE (2005) Echocardiography-based left ventricular mass estimation. How should we define hypertrophy? Cardiovasc Ultrasound 3:17PubMedCrossRefGoogle Scholar
  12. 12.
    Park SH, Shub C, Nobrega TP, Bailey KR, Seward JB (1996) Two-dimensional echocardiographic calculation of left ventricular mass as recommended by the American Society of echocardiography: correlation with autopsy and M-mode echocardiography. J Am Soc Echocardiogr 9:119–128PubMedCrossRefGoogle Scholar
  13. 13.
    Sookoian S, Gianotti TF, Gonzalez CD, Pirola CJ (2007) Association of the C-344T aldosterone synthase gene variant with essential hypertension: a meta-analysis. J Hypertens 25:5–13PubMedCrossRefGoogle Scholar
  14. 14.
    Staessen JA, Li Y, Thijs L (2007) Meta-analysis of blood pressure and the CYP11B2 polymorphism highlights the need for better designed studies. J Hypertens 25:37–39PubMedCrossRefGoogle Scholar
  15. 15.
    Li XM, Ling Y, Lu DR, Lu ZQ, Yi QL, Liu Y et al (2011) Association of the aldosterone synthase gene-344T > C polymorphism with essential hypertension and glucose homeostasis: a case-control study in a Han Chinese population. Clin Exp Pharmacol Physiol 38:598–604PubMedCrossRefGoogle Scholar
  16. 16.
    Yamamoto N, Yasue H, Mizuno Y, Yoshimura M, Fujii H, Nakayama M et al (2002) Aldosterone is produced from ventricles in patients with essential hypertension. Hypertension 39:958–962PubMedCrossRefGoogle Scholar
  17. 17.
    Kupari M, Hautanen A, Lankinen L, Koskinen P, Virolainen J, Nikkila H et al (1998) Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. Circulation 97:569–575PubMedCrossRefGoogle Scholar
  18. 18.
    Tamaki S, Iwai N, Tsujita Y, Kinoshita M (1999) Genetic polymorphism of CYP11B2 gene and hypertension in Japanese. Hypertension 33:266–270PubMedCrossRefGoogle Scholar
  19. 19.
    Kuznetsova T, Staessen JA, Stolarz K, Tikhonoff V, State D, Babeanu S et al (2004) Relationship between left ventricular mass and the ACE D/I polymorphism varies according to sodium intake. J Hypertens 22:287–295PubMedCrossRefGoogle Scholar
  20. 20.
    Sookoian S, Gianotti TF, Pirola CJ (2008) Role of the C-344T aldosterone synthase gene variant in left ventricular mass and left ventricular structure-related phenotypes. Heart 94:903–910PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2012

Authors and Affiliations

  • Sung-Kien Sia
    • 1
    • 2
  • Hui-Ling Chiou
    • 3
  • Shiuan-Chih Chen
    • 4
    • 5
  • Chin-Feng Tsai
    • 1
    • 5
  • Shun-Fa Yang
    • 2
  • Kwo-Chang Ueng
    • 1
    • 5
  1. 1.Department of Internal MedicineChung Shan Medical University HospitalTaichungTaiwan
  2. 2.Institute of MedicineChung Shan Medical UniversityTaichungTaiwan
  3. 3.School of Medical Laboratory and BiotechnologyChung Shan Medical UniversityTaichungTaiwan
  4. 4.Department of Family and Community MedicineChung Shan Medical University HospitalTaichungTaiwan
  5. 5.School of MedicineChung Shan Medical UniversityTaichungTaiwan

Personalised recommendations